Abstract:Radiation therapy prior to surgery has increasingly become the standard of care for locally advanced prostate cancer, however tumor radioresistance remains a major clinical problem. While restoration of microRNA-145 (miR-145) expression reduces chemoradioresistance in glioblastoma and suppress prostate cancer proliferation, migration and invasion, the role of miR-145 in response to radiation therapy for prostate cancer is still unknown. The aim of this study was to investigate the role of miR-145 in determining the tumor response to radiation treatment in prostate cancer. Human prostate cancer cells LNCAP and PC3 were transfected with miR-145 mimic. Clonogenic assay was used to determine whether overexpression of miR-145 could alter radiation response in vitro. Immunofluorescence of γ-H2AX and flow cytometric analysis of phosphorylated histone H3 were performed to investigate the potential mechanisms contributing to the enhanced radiation-induced cell killing induced by miR-145. In addition, a qPCR-based array was used to detect the possible miR-145-mediated regulated genes involved. Tumor growth delay assays and survival curves were then analyzed in an animal model to investigate whether miR-145 induced radiosensitivity in vivo. Furthermore, miR-145 expression was assessed in 30 prostate tumor tissue biopsies taken prior to neoadjuvant radiotherapy using miRNA arrays. Our current study suggested that ectopic expression of miR-145 significantly sensitized prostate cancer cells to radiation and we used γ-H2AX phosphorylation as a surrogate marker of radiotherapy response versus miR-145 expression levels. We observed significantly more foci per cell in the group treated with miR-145 and radiation. In addition, mitotic catastrophe was significantly increased in cells receiving miR-145 and radiation. The above results suggest that miR-145 appears to reduced the efficiency of the repair of radiation-induced DNA double-strand breaks in cells. A detailed examination of the involvement of the DNA repair pathway showed that miR-145 reduced the expression of 10 genes involved in DNA repair according to a qPCR-based array data. Irradiation of subcutaneous PC3 tumors in mice treated with R11-miR-145 (a cellular permeable peptide, previously reported) resulted in an increase in radiation-induced tumor growth delay and lived the longest after combination treatment. Moreover, miR-145 expression was significantly increased in patients demonstrating good response (PSA < 2.0 ng/ml/year) to neoadjuvant radiotherapy, while expression of the miR-145-regulated DNA repair genes was significantly decreased. In conclusion, these data suggest a possible mechanism for miR-145 radiosensitivity, potentially through down regulating of DNA repair. This novel study shows a role for miR-145 in modulating radiosensitivity in vivo and highlights the need for further study investigating the potential role of miR-145 as both a predictive marker of response and a novel therapeutic agent with which to enhance the efficacy of radiation therapy.

Effects of miR-34a on ionizing radiation injuries

Effect of Microrna-34a in Cell Cycle, Differentiation, and Apoptosis: A Review

Ionizing radiation-induced microRNA expression changes in cultured RGC-5 cells

Involvement of miR-605 and miR-34a in the DNA damage response promotes apoptosis induction.

Regulation of Circulating miR-342-3p Alleviates the Radiation-Induced Immune System Injury

Progress in Research on Ionizing Radiation-Induced Microrna

MicroRNA regulation of ionizing radiation-induced premature senescence

Mir-4796 Enhances the Sensitivity of Breast Cancer Cells to Ionising Radiation by Impairing the DNA Repair Pathway.

Role of miR-93-5p and Its Opposing Effect of Ionizing Radiation in Non-Small Cell Lung Cancer

Microrna-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.

Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity

MiR-34 C Acts As a Tumor Suppressor in Non-Small Cell Lung Cancer by Inducing Endoplasmic Reticulum Stress Through Targeting HMGB 1

MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer

MiR-29a Regulates Radiosensitivity in Human Intestinal Cells by Targeting PTEN Gene

Involvement of miRNAs in cellular responses to radiation

miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells.

Changes in patient peripheral blood cell microRNAs after total body irradiation during hematopoietic stem cell transplantation

MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer

Therapeutic Delivery of Mir-29B Enhances Radiosensitivity in Cervical Cancer.

MiR-99a Enhances the Radiation Sensitivity of Non-Small Cell Lung Cancer by Targeting mTOR

MicroRNA and signal transduction pathways in tumor radiation response